- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01950845
Automated Versus Manual Fluid Management for High Risk Abdominal Surgical Patient. A Prospective, Randomized Trial (CL vs CP)
December 13, 2025 updated by: Hospices Civils de Lyon
Per Operative Fluid Optimisation Comparison of an Automated Closed-Loop System Versus Current Practice in High Risk Abdominal Surgical Patient. A Prospective, Randomized Clinical Trial.
Dynamic parameters like pulse pressure variation have been shown to be accurate predictors of fluid responsiveness.
Hemodynamic optimization based on fluid management and stroke volume optimization have been shown to improve patient outcomes, especially for moderate and high risk abdominal surgical patients.
A novel closed-loop fluid administration system based on multi-parameter hemodynamic monitoring have been described recently.
This prospective, randomized, surgeon and patient blinded study aims at comparing the cardiac output provided by either this closed-loop system or the anesthesiologist team in high-rish surgical patient elected for abdominal surgery at Pierre Bénite University Hospital, Hospices Civils of Lyon, France.
Primary endpoint is the mean indexed cardiac output during surgery per group.
We will also compare hemodynamic parameter (cardiac output, stroke volume, blood pressure heart rate…) and patient's outcomes (morbidity, mortality, transfusion rate, hospital length of stay) between groups
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
46
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Pierre-Bénite, France, 69 495
- Centre Hospitalier Lyon Sud, Hospices Civils de Lyon
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Elective major abdominal surgery
- Patient physical status ASA 2-4
- General anesthesia with positive pressure ventilation
- High risk surgical patient with a per operative Vigileo® cardiac output monitoring decided a priori.
Exclusion Criteria:
- Pregnant female
- Intraoperative hyperthermic chemotherapy procedure
- Patient physical status ASA more than 4
- Patient with allergy to hydroxyethyl starch
- Cardiac arrhythmia
- ventilation with tidal volume inferior 7mL/Kg
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Automated fluid management system (Closed-loop system)
cardiac output Vigileo® (Edwards Lifesciences) monitoring is connected to the closed loop system that will automatically provide per operative fluid bolus to optimize cardiac output by automated detection of fluid responsiveness state.
|
Connection of the system to the patient under supervision of the anesthesiologist team during all the anesthesia procedure, respective of the applicability criteria for the fluid responsiveness detection.
|
|
Sham Comparator: Current practice manual fluid management
cardiac output Vigileo® (Edwards Lifesciences) monitoring will be used to help the anesthesiologist team to detect fluid responsiveness state for the manual fluid management optimization
|
The anesthesiologist team will manage the fluid administration during all the anesthesia procedure.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Mean indexed cardiac output
Time Frame: J1 to J12 (Within the surgical hospital length of stay)
|
J1 to J12 (Within the surgical hospital length of stay)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
per operative hemodynamic parameter
Time Frame: J1 (per operative time)
|
J1 (per operative time)
|
|
|
Per operative fluid administration
Time Frame: J1 (per operative)
|
J1 (per operative)
|
|
|
Hospital length of stay
Time Frame: J1 to J12
|
Within the surgical hospital length of stay
|
J1 to J12
|
|
Occurrence of a adverse event after surgery
Time Frame: an expected average of 12 days
|
Within the surgical hospital length of stay
|
an expected average of 12 days
|
|
Occurrence of a death whatever the cause
Time Frame: an expected average of 12 days
|
Within the surgical hospital length of stay
|
an expected average of 12 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2014
Primary Completion (Actual)
October 1, 2015
Study Completion (Actual)
October 1, 2015
Study Registration Dates
First Submitted
September 17, 2013
First Submitted That Met QC Criteria
September 19, 2013
First Posted (Estimated)
September 26, 2013
Study Record Updates
Last Update Posted (Estimated)
December 19, 2025
Last Update Submitted That Met QC Criteria
December 13, 2025
Last Verified
December 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- 2012.770
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hepatectomy
-
Hospital Italiano de Buenos AiresCompleted
-
Rennes University HospitalMinistry of Health, FranceCompleted
-
University Hospital HeidelbergUnknown
-
Sir Run Run Shaw HospitalCompleted
-
Seoul National University HospitalCompleted
-
Zhujiang HospitalNot yet recruitingHepatectomy | HepatolithiasisChina
-
Sichuan UniversityNot yet recruitingLaparoscopic HepatectomyChina
-
Mansoura UniversityCompleted
-
Xuyu ZhangRecruitingLaparoscopic HepatectomyChina
-
Klinikum Saarbrücken, Klinik für Allgemein-, Viszeral-...CompletedLaparoscopic HepatectomyGermany
Clinical Trials on Closed loop automated System (LIR®: learning intravenous resuscitator)
-
Centre Hospitalier Universitaire de NīmesTerminated
-
King's College Hospital NHS TrustKing's College LondonCompletedInfant, Newborn, Diseases | Mechanical Ventilation ComplicationUnited Kingdom
-
King's College Hospital NHS TrustKing's College LondonRecruitingInfant, Premature, Diseases | Airway Morbidity | Mechanical Ventilation ComplicationUnited Kingdom
-
Postgraduate Institute of Medical Education and...CompletedOpen Heart SurgeryIndia
-
Hopital FochTerminated
-
Steno Diabetes Center CopenhagenAarhus University HospitalRecruitingDiabetes Mellitus, Type 1Denmark
-
Kinderkrankenhaus auf der BultCompleted
-
KVG Medical College and HospitalUnknown
-
Norfolk and Norwich University Hospitals NHS Foundation...King's College London; University of Leeds; Belfast Health and Social Care Trust and other collaboratorsCompletedDiabetesUnited Kingdom
-
Hospital San Carlos, MadridFoundation for Biomedical Research and InnovationCompletedCatheterization, PeripheralSpain